Breo(SH:688793) Yang Zi Wan Bao Wang·2025-12-27 07:17Core Viewpoint - The company Beilingsong (倍轻松) is under investigation by the China Securities Regulatory Commission (CSRC) for alleged violations of information disclosure laws, which has led to a significant drop in its stock price and raised concerns about its financial stability [2][3]. Company Overview - Beilingsong is a high-tech enterprise focused on the innovation, research, and development of health products, primarily engaged in the design, production, and sales of smart portable health hardware [3]. - The company has a current market capitalization of 1.943 billion yuan [2][3]. Financial Performance - For the first three quarters of 2025, Beilingsong reported a revenue of 552 million yuan, with a net profit attributable to shareholders of -29.51 million yuan in the third quarter [4]. - The company’s actual controller, Ma Xuejun, recently reduced his stake by transferring 2.97% of the total shares, raising approximately 64.71 million yuan [4]. Recent Developments - On December 25, 2025, the CSRC issued a notice of investigation to Beilingsong and its actual controller Ma Xuejun for suspected information disclosure violations [2]. - In response to the investigation, the company stated that its business operations remain normal and it will cooperate with the CSRC [2]. - Prior to the investigation notice, Ma Xuejun executed a significant share sale, contrasting with another major shareholder, Wang Qiaoqing, who decided to terminate a planned share reduction, citing confidence in the company's long-term development [4]. Capital Needs - On December 23, 2025, just two days before the investigation notice, Beilingsong announced the completion of certain fundraising projects and the decision to permanently supplement its working capital with 19.21 million yuan from the remaining funds [5].